Page last updated: 2024-09-03

nifekalant hydrochloride and Atrial Fibrillation

nifekalant hydrochloride has been researched along with Atrial Fibrillation in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (15.79)18.2507
2000's9 (47.37)29.6817
2010's5 (26.32)24.3611
2020's2 (10.53)2.80

Authors

AuthorsStudies
Chen, Q; Hong, K; Hu, J; Li, J; Wu, Y; Xia, Z; Xiong, Q; Yu, J; Zhai, Z; Zhu, B1
Di, C; Gao, P; Lin, W; Wang, Q; Wu, Y1
Furue, M; Ichiki, T; Mitoma, C; Mukai, Y; Nakahara, T; Nishizaki, A; Uchi, H; Wada, M; Yasukouchi, Y1
Bao, H; Chen, Q; Cheng, X; Fan, S; Hong, K; Hu, J; Huang, L; Huang, Q; Ju, Z; Li, J; Marian, AJ; Wu, Y; Xia, Z; Xiong, Q; You, C; Yu, J; Yuan, P; Zhu, B1
Hirayama, A; Kofune, M; Kogawa, R; Mano, H; Nakai, T; Ohkubo, K; Okumura, Y; Sasaki, N; Sonoda, K; Watanabe, I1
Enjoji, Y; Funatsu, A; Kambayashi, D; Kobayashi, T; Mizobuchi, M; Nakamura, S; Ono, T; Yamamoto, R1
Hirayama, A; Kofune, M; Mano, H; Nagashima, K; Ohkubo, K; Okumura, Y; Sonoda, K; Watanabe, I1
Kumagai, K; Toyama, H1
Aoyagi, T; Fukushima, K; Kobayakawa, N; Otani, Y; Sawaki, D; Sekita, G; Takeuchi, H1
Centurion, OA; Fukae, S; Isomoto, S; Komiya, N; Minami, T; Nakao, K; Yano, K1
Kofune, T; Masaki, R; Okubo, K; Okumura, Y; Saito, S; Shindo, A; Watanabe, I1
Hayashi, M; Kato, T; Kobayashi, Y; Morita, N; Sato, N; Takano, T; Tanaka, K; Yasutake, M1
Sugi, K1
Azegami, K; Hirao, K; Isobe, M; Miyagi, N; Nakamura, K; Ohba, K; Okishige, K; Shimabukuro, M; Uehara, H; Wakimoto, H1
Hara, Y; Masuda, Y; Mori, K; Nakaya, H; Saito, T1
Centurion, OA; Hayano, M; Hirata, T; Isomoto, S; Kaibara, M; Konoe, A; Yano, K1
Fujiki, A; Hayashi, H; Inoue, H; Tani, M; Usui, M1
Kanmatuse, K; Kojima, T; Kunimoto, S; Masaki, R; Nakai, T; Oshikawa, N; Ozawa, Y; Saito, S; Watanabe, H; Watanabe, I1
Fuda, Y; Hagiwara, N; Haruta, S; Kasanuki, H; Matsuda, N; Shiga, T1

Reviews

1 review(s) available for nifekalant hydrochloride and Atrial Fibrillation

ArticleYear
[Strategy for cardiac arrhythmias in acute coronary syndrome].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64, Issue:4

    Topics: Amiodarone; Angina, Unstable; Anti-Asthmatic Agents; Aprindine; Atrial Fibrillation; Bepridil; Electric Countershock; Humans; Myocardial Infarction; Potassium Channel Blockers; Pyrimidinones; Recurrence; Syndrome; Tachycardia, Ventricular; Ventricular Fibrillation

2006

Trials

4 trial(s) available for nifekalant hydrochloride and Atrial Fibrillation

ArticleYear
Comparison of the efficacy and safety of different doses of nifekalant in the instant cardioversion of persistent atrial fibrillation during radiofrequency ablation.
    Basic & clinical pharmacology & toxicology, 2021, Volume: 128, Issue:3

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Electrocardiography; Female; Humans; Male; Middle Aged; Pyrimidinones; Radiofrequency Ablation

2021
Usefulness of ablation of complex fractionated atrial electrograms using nifekalant in persistent atrial fibrillation.
    Journal of cardiology, 2013, Volume: 61, Issue:1

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Combined Modality Therapy; Electrocardiography; Female; Humans; Male; Middle Aged; Prospective Studies; Pyrimidinones; Treatment Outcome

2013
Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.
    Journal of cardiovascular electrophysiology, 2005, Volume: 16, Issue:7

    Topics: Aged; Aging; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Hemodynamics; Hospital Mortality; Humans; Male; Middle Aged; Premedication; Prognosis; Pyrimidinones; Secondary Prevention; Treatment Failure; Treatment Outcome

2005
Clinical study of the acute effects of intravenous nifekalant on the defibrillation threshold in patients with persistent and paroxysmal atrial fibrillation.
    Circulation journal : official journal of the Japanese Circulation Society, 2008, Volume: 72, Issue:1

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Electric Countershock; Female; Humans; Male; Middle Aged; Pyrimidinones; Treatment Outcome

2008

Other Studies

14 other study(ies) available for nifekalant hydrochloride and Atrial Fibrillation

ArticleYear
Intraprocedural Conversion Efficacy of Intravenous Nifekalant Administration for Persistent Atrial Fibrillation after Pulmonary Vein Isolation.
    International heart journal, 2020, Nov-28, Volume: 61, Issue:6

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cryosurgery; Electric Countershock; Female; Heart Atria; Humans; Infusions, Intravenous; Intraoperative Care; Intraoperative Complications; Male; Middle Aged; Organ Size; Peripheral Nerve Injuries; Phrenic Nerve; Progression-Free Survival; Prospective Studies; Pulmonary Veins; Pyrimidinones; Recurrence; Tachycardia, Ventricular; Treatment Outcome

2020
Crystallization granuloma by nifekalant hydrochloride infusion.
    Geriatrics & gerontology international, 2018, Volume: 18, Issue:7

    Topics: Aged; Atrial Fibrillation; Biopsy, Needle; Crystallization; Follow-Up Studies; Foot; Granuloma; Hand; Humans; Immunohistochemistry; Infusions, Intravenous; Male; Pyrimidinones; Rare Diseases; Risk Assessment

2018
Efficacy of Nifekalant in Patients With Wolff-Parkinson-White Syndrome and Atrial Fibrillation: Electrophysiological and Clinical Findings.
    Journal of the American Heart Association, 2019, 07-02, Volume: 8, Issue:13

    Topics: Accessory Atrioventricular Bundle; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Pyrimidinones; Tachycardia, Supraventricular; Ventricular Dysfunction, Left; Wolff-Parkinson-White Syndrome

2019
Rate-dependent electrophysiologic effects of the class III antiarrhythmic drugs nifekalant, amiodarone, and ibutilide on the atrium in patients with persistent atrial fibrillation.
    International heart journal, 2013, Volume: 54, Issue:5

    Topics: Action Potentials; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Female; Heart Atria; Heart Conduction System; Humans; Male; Middle Aged; Pyrimidinones; Sulfonamides

2013
Nifekalant and disopyramide in a patient with short QT syndrome: evaluation of pharmacological effects and electrophysiological properties.
    Pacing and clinical electrophysiology : PACE, 2008, Volume: 31, Issue:9

    Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Body Surface Potential Mapping; Disopyramide; Humans; Male; Pyrimidinones; Syndrome; Tachycardia, Ventricular; Treatment Outcome; Young Adult

2008
Pharmacologic atrial defibrillation by drug delivery into the temporarily occluded coronary sinus. A canine study.
    International heart journal, 2012, Volume: 53, Issue:2

    Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Balloon Occlusion; Cardiac Pacing, Artificial; Chronic Disease; Coronary Sinus; Dogs; Drug Delivery Systems; Injections, Intravenous; Lidocaine; Pyrimidinones; Treatment Outcome

2012
Pretreatments with a novel pure potassium channel blocker, Nifekalant, were effective in the electrical atrial defibrillation: a report of two cases.
    Cardiovascular drugs and therapy, 2002, Volume: 16, Issue:6

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Defibrillators, Implantable; Electric Countershock; Female; Humans; Male; Potassium Channel Blockers; Pyrimidinones

2002
Effects of intravenous nifekalant, a class III antiarrhythmic drug, on atrial vulnerability parameters in patients with paroxysmal atrial fibrillation.
    Pacing and clinical electrophysiology : PACE, 2004, Volume: 27, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Appendage; Atrial Fibrillation; Atrial Function; Bundle of His; Coronary Vessels; Electrocardiography; Electrophysiology; Female; Heart Ventricles; Humans; Infusions, Intravenous; Linear Models; Male; Matched-Pair Analysis; Middle Aged; Pyrimidinones; Refractory Period, Electrophysiological; Time Factors

2004
Effect of IKr blocker nifekalant on atrial action potential duration after successful internal cardioversion of chronic atrial fibrillation.
    Pacing and clinical electrophysiology : PACE, 2005, Volume: 28, Issue:5

    Topics: Action Potentials; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Electric Countershock; Female; Heart Atria; Heart Rate; Humans; Male; Middle Aged; Pyrimidinones; Refractory Period, Electrophysiological

2005
Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells. Different molecular mechanisms.
    Circulation, 1995, Jun-01, Volume: 91, Issue:11

    Topics: Acetylcholine; Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrial Function, Left; Cells, Cultured; Guinea Pigs; Heart Atria; In Vitro Techniques; Myocardial Contraction; Patch-Clamp Techniques; Piperidines; Potassium Channels; Pyridines; Pyrimidinones; Receptors, Muscarinic; Sotalol

1995
Electrophysiological effects of MS-551 in humans: a class III antiarrhythmic agent.
    Pacing and clinical electrophysiology : PACE, 1995, Volume: 18, Issue:11

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Blood Pressure; Bundle of His; Electrocardiography; Electrophysiology; Female; Heart Atria; Heart Rate; Heart Ventricles; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Pyrimidinones; Refractory Period, Electrophysiological; Sinoatrial Node; Tachycardia

1995
Different effects of class Ic and III antiarrhythmic drugs on vagotonic atrial fibrillation in the canine heart.
    Journal of cardiovascular pharmacology, 1998, Volume: 31, Issue:1

    Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Dogs; Electric Stimulation; Female; Lidocaine; Male; Pyrimidinones; Vagus Nerve

1998
Frequency-dependent electrophysiological effects of flecainide, nifekalant and d,l-sotalol on the human atrium.
    Japanese circulation journal, 2001, Volume: 65, Issue:1

    Topics: Action Potentials; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Cohort Studies; Drug Evaluation; Electrophysiologic Techniques, Cardiac; Flecainide; Heart Atria; Humans; Middle Aged; Pyrimidinones; Sotalol

2001
Antiarrhythmic effect of nifekalant on atrial tachyarrhythmia in four patients with severe heart failure.
    Journal of cardiology, 2002, Volume: 39, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Pyrimidinones; Tachycardia

2002